Cargando…

Drug-coated balloons for the treatment of stent edge restenosis

Drug-coated balloon (DCB) is a device for treating patients with in-stent restenosis; however, there are scant data on its efficacy for stent edge restenosis (SER). This study aimed to investigate the clinical outcomes of DCB use for treating SER compared with new-generation drug-eluting stent (DES)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagasaka, Takashi, Amanai, Shiro, Ishibashi, Yohei, Aihara, Kazufumi, Ohyama, Yoshiaki, Takama, Noriaki, Koitabashi, Norimichi, Ishii, Hideki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132460/ https://www.ncbi.nlm.nih.gov/pubmed/36951740 http://dx.doi.org/10.1097/MCA.0000000000001235

Ejemplares similares

Acute pulmonary thromboembolism after messenger RNA vaccination against coronavirus disease 2019: A case report
por: Ishibashi, Yohei, et al.
Publicado: (2023)

Acute myocarditis associated with COVID-19 vaccination: A case report
por: Nagasaka, Takashi, et al.
Publicado: (2021)

Adaptive Servo-ventilation Therapy Results in the Prevention of Arrhythmias in Patients with Heart Failure Due to Ischemic Heart Disease
por: Nagasaka, Takashi, et al.
Publicado: (2021)

Remarkable regression of massive deep vein thrombosis in response to intensive oral rivaroxaban treatment
por: Koitabashi, Norimichi, et al.
Publicado: (2015)

What Is the Future of Drug-Coated Balloons for In-Stent Restenosis?
por: Chen, Yun-Dai, et al.
Publicado: (2022)

Drug-coated balloon in superficial femoral artery in-stent restenosis
por: Gerardi, Donato, et al.
Publicado: (2018)

A case of a middle-aged patient with a ventricular septal defect complicated by severe pulmonary hypertension-stepwise surgical repair with pulmonary vasodilators-
por: Kanai, Anna, et al.
Publicado: (2021)

Long-term efficacy of drug-coated balloon for renal artery in-stent restenosis
por: Elwany, Mostafa, et al.
Publicado: (2018)

Feasibility and Safety of Paclitaxel-Coated Balloon Angioplasty for the Treatment of Intracranial Symptomatic In-Stent Restenosis
por: Xu, Haowen, et al.
Publicado: (2020)

Drug-Coated Balloon for the Treatment of Femoropopliteal Tosaka Class III In-stent Restenosis Lesions
por: Zhang, Bihui, et al.
Publicado: (2021)

Efficacy and Prediction Model Construction of Drug-Coated Balloon Combined with Cutting Balloon Angioplasty in the Treatment of Drug-Eluting Stent In-Stent Restenosis
por: Wu, Haokun, et al.
Publicado: (2022)

No-Reflow Phenomenon During Treatment of Coronary In-Stent Restenosis With a Paclitaxel-Coated Balloon Catheter
por: Chung, Han-Hee, et al.
Publicado: (2012)

Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trials
por: Navarese, Eliano Pio, et al.
Publicado: (2012)

Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
por: Horie, Kazunori, et al.
Publicado: (2021)

Prognostic value of post-procedural μQFR for drug-coated balloons in the treatment of in-stent restenosis
por: Liu, Lili, et al.
Publicado: (2023)

Serial optical coherence tomography and angioscopic assessments of 10-year in-stent restenosis of Cypher sirolimus-eluting stent treated with drug-coated balloon angioplasty
por: Suzuki, Satoshi, et al.
Publicado: (2019)

Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis
por: Xue, Weihao, et al.
Publicado: (2022)

Debulking plus drug-coated balloon angioplasty versus drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions
por: Li, Liqiang, et al.
Publicado: (2022)

Drug-coated balloon angioplasty versus balloon angioplasty for treating patients with in-stent restenosis in the femoropopliteal artery: A meta-analysis
por: Cao, Shaobo, et al.
Publicado: (2021)

Comparison of 2 Different Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis: A Randomized Controlled Trial
por: Jun, Eun Jung, et al.
Publicado: (2022)

Coronary Artery Perforation After Balloon Dilatation for Recurrent In-Stent Restenosis Inside the Double-Layered Previous Stents
por: Yamashita, Daichi, et al.
Publicado: (2023)

Nonbacterial Thrombotic Endocarditis—A Rare Case of Acute Libman-Sacks Endocarditis Complicated by Multiple Cerebral Infarcts: Case Report and Literature Review
por: Kato, Toshimitsu, et al.
Publicado: (2020)

Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis
por: Nijhoff, Freek, et al.
Publicado: (2015)

Two Years Efficacy of Paclitaxel-Coated Balloon Dilation for In-Stent Renal Artery Restenosis Due to Takayasu Arteritis
por: Yamamoto, Tomohiko, et al.
Publicado: (2019)

Drug-Coated Balloon Angioplasty and Debulking for the Treatment of Femoropopliteal In-Stent Restenosis: A Systematic Review and Meta-Analysis
por: Tong, Zhu, et al.
Publicado: (2020)

The Diagnostic Value of Circulating Biomarkers and Role of Drug-Coated Balloons for In-Stent Restenosis in Patients with Peripheral Arterial Disease
por: Montelione, Nunzio, et al.
Publicado: (2022)

Impact of the Distance from the Stent Edge to the Residual Plaque on Edge Restenosis following Everolimus-Eluting Stent Implantation
por: Takahashi, Masao, et al.
Publicado: (2015)

Drug-Coated Balloons versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis: A Pair-Wise Meta-Analysis of Randomized Trials
por: Peng, Nina, et al.
Publicado: (2020)

The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty
por: Oh, Pyung Chun, et al.
Publicado: (2016)

Coated stents to prevent restenosis in coronary heart disease
por: Gorenoi, Vitali, et al.
Publicado: (2005)

Neoatherosclerosis causing edge in-stent restenosis: optical coherence tomography findings
por: Alfonso, F., et al.
Publicado: (2015)

In-Stent Restenosis and a Drug-Coated Balloon: Insights from a Clinical Therapeutic Strategy on Coronary Artery Diseases
por: Zhang, Dai-Min, et al.
Publicado: (2020)

Treatment of In-Stent Restenosis by Excimer Laser Coronary Atherectomy and Drug-Coated Balloon: Serial Assessment with Optical Coherence Tomography
por: Miyazaki, Toru, et al.
Publicado: (2019)

Intravascular ultrasound-guided drug-coated balloon venoplasty for in-stent restenosis in pulmonary veins stenosis: a case report
por: Portero-Portaz, Juan J, et al.
Publicado: (2021)

Comparison of new-generation drug-eluting stents versus drug-coated balloon for in-stent restenosis: a meta-analysis of randomised controlled trials
por: Cai, Jin-Zan, et al.
Publicado: (2018)

Local drug-delivery balloon for proliferative occlusive in-stent restenosis after drug-eluting stent
por: Rigatelli, Gianluca, et al.
Publicado: (2011)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

Unusual Response of Subclavian In-Stent Restenosis to Balloon Angioplasty in a Patient with HIV
por: Rana, Mohammad Atif, et al.
Publicado: (2015)

Clinical implication of quantitative flow ratio to predict clinical events after drug‐coated balloon angioplasty in patients with in‐stent restenosis
por: Tang, Jiani, et al.
Publicado: (2021)

Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis
por: Abdelmegid, Mohamed Aboel-Kassem F., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7c1bc35gqpohrqv9p9g4lh44ei